The recurrence of skin and soft tissue infections (SSTIs) caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and community-associated methicillin-sensitive Staphylococcus aureus (CA-MSSA) (range, 16%-43%) presents significant challenges to clinicians, patients, and families.
